- Conditions
- Infertility
- Interventions
- DR-2011, Crinone 8%
- Drug
- Lead sponsor
- Duramed Research
- Industry
- Eligibility
- 18 Years to 42 Years · Female only
- Enrollment
- 1,297 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 29
- States / cities
- Tarzana, California • West Los Angeles, California • Westlake, California + 26 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–32
of 32
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Pregnancy Complications
- Interventions
- Progesterone, Polyethylene glycol&hydrogenated vegetable oil.
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 55 Years · Female only
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2015
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Short Cervical Length
- Interventions
- Vaginal progesterone, Placebo, Arabin Pessary
- Drug · Device
- Lead sponsor
- The George Washington University Biostatistics Center
- Other
- Eligibility
- Female only
- Enrollment
- 1,311 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2025
- U.S. locations
- 16
- States / cities
- Birmingham, Alabama • San Francisco, California • Denver, Colorado + 12 more
- Conditions
- Infant, Premature, Premature Birth
- Interventions
- Intramuscular Progesterone, Vaginal Progesterone
- Drug
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 174 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2011
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Pregnancy Related
- Interventions
- micronized Progesterone
- Drug
- Lead sponsor
- Thomas Jefferson University
- Other
- Eligibility
- 16 Years to 55 Years · Female only
- Enrollment
- 3 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Coronary Heart Disease
- Interventions
- Ethinyl Estradiol-Levonorgestrel combination, leuprolide acetate, Estradiol, Progesterone
- Drug
- Lead sponsor
- Oregon Health and Science University
- Other
- Eligibility
- 21 Years to 40 Years · Female only
- Enrollment
- 5 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Portland, Oregon
- Conditions
- Progesterone Supplementation in Women Undergoing ART
- Interventions
- Progesterone vaginal ring
- Drug
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 34 Years · Female only
- Enrollment
- 352 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 15
- States / cities
- Tempe, Arizona • Encino, California • Newark, Delaware + 12 more
- Conditions
- Menopause
- Interventions
- oral estradiol 1.0 mg, oral progesterone 100 mg
- Drug
- Lead sponsor
- Intira Sriprasert
- Other
- Eligibility
- 20 Years to 65 Years · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2018
- U.S. locations
- 1
- States / cities
- Norfolk, Virginia